CABERMED 0.5 (Cabergoline) EXP: 10/2024

CABERMED 0.5 (Cabergoline) belongs to a class of drugs called dopamine agonists. It is used to treat disorders of excess prolactin production, and can also be used to manage Parkinson’s’ syndrome. It is manufactured as Cabergoline 0.5mg tablets which contain 0.5mg Carbegoline and excipients.

Cabergoline Mechanism of Action

Cabergoline is a dopamine agonist, and it acts on the dopaminergic receptors (most active on D2) to cause the secretion of dopamine. Dopamine is a neurotransmitter that inhibits prolactin production in the pituitary gland. Its half-life ranges from 63 – 69 hours.

Cabergoline Dosage

0.25mg orally twice a week.

Cabergoline Side Effects

Nausea, vomiting, constipation insomnia, depression, hypotension peripheral edema arrhythmias.

Disclaimer

The information provided above is not intended to substitute medical advice, diagnosis, or treatment. Should you have any questions regarding a medical condition, seek the advice of your physician or a qualified healthcare provider. In no case should medical advice be disregarded or delayed because of what you have read or seen. We bear no responsibility or liability for your use of any of our research compounds and products. Please note that they are being sold for research purposes ONLY. We do NOT condone any personal use.